Exposed positively charged proteins and glycoproteins on damaged gastrointestinal mucosa

Exposed positively charged proteins and glycoproteins on damaged gastrointestinal mucosa serve as a localized pharmacological target for cytoprotective agents like sucralfate (StatPearls, 2023). When the gastric or duodenal mucosa is eroded, proteins such as albumin and fibrinogen are exposed and carry a net positive charge in the acidic environment of the stomach (PubMed, PMID: 6389110). These proteins interact electrostatically with negatively charged molecules, specifically the sucrose octasulfate component of sucralfate, to form a stable, insoluble complex (NIH, PubChem). This complex acts as a physical bandage or barrier that protects the ulcerated site from aggressive factors like gastric acid, pepsin, and bile salts, thereby promoting mucosal healing (FDA Label, Carafate). This target is central to the management of peptic ulcer disease and stress-related mucosal damage, providing a site-specific therapeutic effect without requiring systemic absorption. The binding affinity for these proteins is significantly higher in damaged tissue compared to healthy mucosa, ensuring targeted delivery of the protective agent. By shielding the ulcer crater, these proteins facilitate the accumulation of growth factors and the migration of epithelial cells necessary for tissue regeneration.

Other names

Ulcerated tissue proteinsExposed mucosal proteinsGastric ulcer exudate proteinsUlcer base proteins

The mechanism involves the electrostatic binding of negatively charged sucrose octasulfate to positively charged proteins (e.g., albumin, fibrinogen) exposed in the ulcer crater, forming a protective physical barrier (StatPearls, 2023).